Stockreport

Intercept Announces First Patient Dosed In Phase 2 Study Of OCA And Bezafibrate For The Treatment Of Primary Biliary Cholangitis [TheStreet.com]

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
PDF MORRISTOWN, N.J., May 11, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercializ [Read more]